Actionnariat et activité des initiés pour CAMP4 Therapeutics Corporation (CAMP): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $3.86 |
| Capitalisation | $82M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-08-31 | Gold Kelly | P-Purchase | 10,000 | $40K |
| 2026-08-27 | Schwab Andrew J. | S-Sale | 400,000 | $1.6M |
| 2026-08-24 | Schwab Andrew J. | S-Sale | 10 | $45 |
| 2026-08-19 | Schwab Andrew J. | S-Sale | 45,147 | $215K |
| 2026-08-20 | Schwab Andrew J. | S-Sale | 114,700 | $521K |
| 2026-08-21 | Schwab Andrew J. | S-Sale | 32,018 | $144K |
| 2026-08-19 | Tardiff Daniel | S-Sale | 1,738 | $8K |
| 2026-08-03 | 5AM Partners VI, LLC | P-Purchase | 3,179,558 | $318 |
| 2026-08-03 | Schwab Andrew J. | A-Award | 3,179,558 | $318 |
| 2026-08-03 | Young Richard A | P-Purchase | 16,378 | $27K |
Bilan (10 ans)
| Année | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $93.7M | $132.6M | $256.5M | $107.4M | $91.7M | $91.1M | $83.2M | $38.4M | $64.0M | $109.5M |
| Placements à Court Terme | $6.7M | $23.4M | $17.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Créances | $67.4M | $71.6M | $78.1M | $72.3M | $67.9M | $58.6M | $678000 | $442000 | $108000 | $155000 |
| Stocks | $29.3M | $36.3M | $32.0M | $36.8M | $32.2M | $20.2M | 0 | 0 | 0 | 0 |
| Actifs Courants | $206.7M | $275.9M | $403.5M | $237.9M | $215.2M | $193.6M | $84.4M | $40.0M | $66.4M | $114.1M |
| Immobilisations Corporelles | $21.2M | $21.3M | $27.0M | $76.5M | $62.2M | $50.1M | $16.8M | $13.3M | $10.3M | $2.7M |
| Goodwill | $73.0M | $73.0M | $80.8M | $106.3M | $94.5M | $94.0M | 0 | 0 | 0 | 0 |
| Actifs Incorporels | $67.2M | $52.5M | $47.2M | $45.9M | $38.9M | $33.0M | 0 | 0 | 0 | 0 |
| Actifs Totaux | $407.7M | $473.0M | $603.6M | $495.8M | $441.8M | $402.3M | $102.5M | $54.9M | $78.3M | $117.8M |
| Dettes Fournisseurs | $30.3M | $35.5M | $39.9M | $28.4M | $36.8M | $30.8M | $2.2M | $1.0M | $1.2M | $182000 |
| Dette à Court Terme | $11.0M | $32.2M | $36.8M | $37.8M | $10.9M | $7.7M | 0 | 0 | 0 | $286000 |
| Passifs Courants | $76.6M | $95.5M | $83.6M | $121.5M | $107.4M | $94.9M | $7.9M | $7.8M | $9.6M | $15.5M |
| Dette à Long Terme | $146.8M | $154.3M | $275.9M | $201.4M | $199.9M | $201.4M | 0 | 0 | 0 | $1.7M |
| Passifs Totaux | $243.7M | $274.1M | $398.0M | $357.9M | $342.5M | $322.1M | $180.1M | $178.7M | $15.2M | $70.1M |
| Réserves | -$47.0M | -$19.5M | -$2.2M | -$81.5M | -$129.2M | -$156.8M | -$110.7M | -$160.0M | -$211.8M | -$292.2M |
| Capitaux Propres | $164.0M | $198.9M | $205.7M | $137.9M | $99.3M | $80.2M | -$77.5M | -$123.7M | $63.1M | $47.7M |
| Dette Totale | $146.8M | $154.3M | $275.9M | $234.5M | $210.8M | $209.2M | $12.4M | $11.7M | $8.6M | $2.0M |
| Dette Nette | $46.4M | -$1.7M | $1.9M | $127.1M | $119.1M | $118.1M | -$70.8M | -$26.7M | -$55.4M | -$107.5M |
| Fonds de Roulement | $130.1M | $180.4M | $319.9M | $116.4M | $107.8M | $98.7M | $76.5M | $32.2M | $56.8M | $98.6M |
Santé financière
| Dette / Capitaux propres | -3.42 |
| Ratio de liquidité | 4.70 |
Rentabilité
| Rentabilité des capitaux propres | -314.08% |
| Rentabilité du capital investi | -69.76% |
| Rentabilité des actifs | -114.79% |
| Marge brute | 77.80% |
| Marge opérationnelle | -1242.50% |
| Marge nette | -2543.74% |
Entreprises liées: ACRV · ALXO · ATYR · BMEA · HYFT · PMVP · QNCX
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de CAMP: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions